This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Application of observational research methods to real-world studies for rare disease drugs: A scoping review protocol.
PloS one · 2025
Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data.
JAMA oncology · 2025 · senior author
Trends in the Cost and Utilization of Publicly Reimbursed Cancer Medications Dispensed as Take-Home Treatments from 2017-2021.
Current oncology (Toronto, Ont.) · 2025
Latest funding
- $1,487,925
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2025 · Co-investigator
- $100,000
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2024 · Co-investigator
- $153,000
Understanding the impact of age and frailty on immune checkpoint inhibitor (ICI) outcomes in cancer patients
CIHR · 2024 · Principal investigator
45 publications.
Application of observational research methods to real-world studies for rare disease drugs: A scoping review protocol.
Patel YP, Ghaddar L, Lin Y, Karim N, Chan K, Dupuis L, Tadrous M
Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data.
Grant RC, He JC, Liu N, Podolsky S, Notta F, Ghassemi M, Gallinger S, Knezevic A, Latcha S, Jaimes E, Kitchlu A, Chan K
Trends in the Cost and Utilization of Publicly Reimbursed Cancer Medications Dispensed as Take-Home Treatments from 2017-2021.
Garg R, Dumont T, McCormack D, Tadrous M, Campbell T, Chan K, Gomes T
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study.
Arya S, Mozessohn L, Gong I, Faught N, Liu N, Singh S, Chan K, Cheung MC
Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making.
Tadrous M, Aves T, Fahim C, Riad J, Mittmann N, Prieto-Alhambra D, Rivera DR, Chan K, Lix LM, Kent S, Dawoud D, Guertin JR, McDonald JT, Round J, Klarenbach S, Stanojevic S, De Vera MA, Strumpf E, Platt RW, Husein F, Lambert L, Hayes KN
Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making
Gauvreau CL, Schreyer L, Gibson PJ, Koo A, Ungar WJ, Regier D, Chan K, Hayeems R, Gibson J, Palmer A
Patient, Family, Caregiver, and Community Engagement in Research: A Sensibility Evaluation of a Novel Infographic and Planning Guide
Giannini AT, Leong M, Chan K, Ghaltaei A, Graham E, Robinson C, Skorska MN, Cross A, Gabison S
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.
Kc S, Lin LW, Bayani DBS, Zemlyanska Y, Adler A, Ahn J, Chan K, Choiphel D, Genuino-Marfori AJ, Kearney B, Liu Y, Nakamura R, Pearce F, Prinja S, Pwu RF, Akmal Shafie A, Sui B, Suwantika A, Tunis S, Wu HM, Zalcberg J, Zhao K, Isaranuwatchai W, Teerawattananon Y, Wee HL
Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
Forner D, Mok F, Verma N, Karam I, Goldstein D, Higgins K, Enepekides D, Nadler A, Pugash R, Husain Z, Chan K, Smoragiewicz M, Cohen L, Hazey JW, Fung EC, Kang SY, Seim NB, Simpson C, Eskander A
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada.
Regier DA, Pollard S, McPhail M, Bubela T, Hanna TP, Ho C, Lim HJ, Chan K, Peacock SJ, Weymann D
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
Principal investigators: Abdel-Qadir, Husam-Eldin M; Amir, Eitan
Keywords: Cardiac Imaging; Cardiotoxicity; Echocardiography; Heart Failure; Her-2 Positive Breast Cancer; Left Ventricular Ejection Fraction; Non-Inferiority; Nuclear Imaging; Randomized Controlled Trial; Trastuzumab
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
Principal investigators: Abdel-Qadir, Husam-Eldin M; Amir, Eitan
Keywords: Cardiac Imaging; Cardiotoxicity; Echocardiography; Heart Failure; Her-2 Positive Breast Cancer; Left Ventricular Ejection Fraction; Non-Inferiority; Nuclear Imaging; Randomized Controlled Trial; Trastuzumab
Understanding the impact of age and frailty on immune checkpoint inhibitor (ICI) outcomes in cancer patients
Principal investigators: Eng, Lawson; Alibhai, Shabbir M; Chan, Kelvin K
Keywords: Acute Care Use; Cancer; Geriatric Oncology; Immunotherapy; Older Adults; Outcomes Research; Predictive Modelling; Statistical Machine Learning; Supportive Care; Survivorship
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
Principal investigators: Abdel-Qadir, Husam-Eldin M; Amir, Eitan
Keywords: Cardiac Imaging; Cardiotoxicity; Choosing Wisely; Echocardiography; Heart Failure; Her-2 Positive Breast Cancer; Left Ventricular Ejection Fraction; Non-Inferiority; Randomized Controlled Trial; Trastuzumab
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
Principal investigators: Chan, Kelvin K; Peacock, Stuart J
Keywords: Annual Conference/Meeting; Cancer Survivorship; Health Services Research; Health Technology Assessment; Knowledge Translation; Societal Values And Public Engagement
Personalized Genetic Drug Technologies and Medical Economies in Canada: Moral Experiment or Curative Renaissance?
Principal investigators: Bell, Jennifer A.H.
Keywords: bioethics; public deliberation; patient and caregiver engagement; qualitative methods; critical ethnography; personalized medicine
Personalized Genetic Drug Technologies and Medical Economies in Canada: Moral Experiment or Curative Renaissance?
Principal investigators: Bell, Jennifer A.H.
Keywords: bioethics; public deliberation; patient and caregiver engagement; qualitative methods; critical ethnography; personalized medicine
An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
Principal investigators: Lukovic, Jelena; O'Callaghan, Christopher J
Keywords: Esophagectomy; Radiotherapy; Randomized Trial; Squamous Cell Carcinoma Esophagus
The Tsunami after the Earthquake: COVID-19 Impact on Cancer Care and Outcomes
Principal investigators: Eskander, Antoine; Sutradhar, Rinku
Keywords: Cancer; Chemotherapy; Health Disparities; Health Services Research; Modified Delphi Method; Pandemic; Radiation; Screening; Surgery; Wait-Times
Expediting the drug approval process in oncology through access with evidence development schemes
Principal investigators: Heath, Anna; Pechlivanoglou, Petros
Keywords: Market Access With Evidence Development; Novel Cancer Therapies; Reimbursement Decision Making; Research Design And Prioritisation; Routinely Collected Health Data; Value Of Information
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Health Research Methods, Evidence, and Impact
- Oncology
- Institute of Health Policy, Management, and Evaluation
- Radiation Oncology
- Medicine
- Toronto General Research Institute
- Department of Otolaryngology - Head and Neck Surgery
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Wanrudee Isaranuwatchai
Faculty
5 shared papers, latest 2023
Mina Tadrous
Faculty
4 shared papers, latest 2025
Nicole Mittmann
Faculty
3 shared papers, latest 2024
Murray Krahn
Toronto General Research Institute
3 shared papers, latest 2020
Danny Enepekides
Department of Otolaryngology - Head and Neck Surgery
2 shared papers, latest 2022
Stuart Peacock
Faculty
2 shared papers, latest 2024
Ning Liu
Institute of Health Policy, Management, and Evaluation
2 shared papers, latest 2025
Simron Singh
Faculty
2 shared papers, latest 2024
Antoine Eskander
Faculty
2 shared papers, latest 2022
Tammy Clifford
School of Epidemiology and Public Health
2 shared papers, latest 2019
Claire de Oliveira
Institute of Health Policy, Management, and Evaluation
2 shared papers, latest 2020
William Evans
Oncology
2 shared papers, latest 2020
Michael Zoratti
Health Research Methods, Evidence, and Impact
2 shared papers, latest 2019
Gordon Guyatt
Health Research Methods, Evidence, and Impact
2 shared papers, latest 2019
Oren Levine
Oncology
2 shared papers, latest 2019
Holger Schunemann
Health Research Methods, Evidence, and Impact
2 shared papers, latest 2019
Fei-Fei Liu
Radiation Oncology
2 shared papers, latest 2013
Feng Xie
Health Research Methods, Evidence, and Impact
2 shared papers, latest 2019
Dean Regier
Cancer Control Research
1 shared papers, latest 2024
Faiyaz Notta
Medical Biophysics
1 shared papers, latest 2025
Anna Spreafico
Faculty
1 shared papers, latest 2014
Alyson Mahar
Community Health Sciences
1 shared papers, latest 2021
John Kim
Neuropsychology
1 shared papers, latest 2016
Andrew Hope
Radiation Oncology
1 shared papers, latest 2016
Christine Fahim
Centre for Urban Health Solutions
1 shared papers, latest 2024
Lee Mozessohn
Faculty
1 shared papers, latest 2024
Ekaterina Kosyachkova
Faculty
1 shared papers, latest 2021
Sanja Stanojevic
Community Health and Epidemiology
1 shared papers, latest 2024
Kimberlyn McGrail
Emergency Medicine
1 shared papers, latest 2021
Andrea Eisen
Faculty
1 shared papers, latest 2014
Paul Karanicolas
Surgery
1 shared papers, latest 2021
Michal Abrahamowicz
Clinical Epidemiology
1 shared papers, latest 2020
Linda Rabeneck
Clinical Public Health Division
1 shared papers, latest 2018
Sasha Bernatsky
Medicine
1 shared papers, latest 2020
Marie Hudson
Psychiatry
1 shared papers, latest 2020
Louise Pilote
Cardiology
1 shared papers, latest 2020
Hsien Seow
Oncology
1 shared papers, latest 2021
Andrea Eisen
Oncology
1 shared papers, latest 2014
Paul Gibson
Pediatrics
1 shared papers, latest 2024
Andrea Cross
Pediatrics
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.